8/7/2019 arrhythmeia2Qnz2

http://slidepdf.com/reader/full/arrhythmeia2qnz2 1/8

001. This drug is a Class IA antiarrhythmic drug:

a) Sotalol

b) Propranolol

c) Verapamil

d) Quinidine

002. This drug is a Class IC antiarrhythmic drug:

a) Flecainide

b) Sotalol

c) Lidocaine

d) Verapamil

003. This drug is a Class IC antiarrhythmic drug:a) Flecainide

b) Sotalol

c) Lidocaine

d) Verapamil

Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.

d

a

a

8/7/2019 arrhythmeia2Qnz2

http://slidepdf.com/reader/full/arrhythmeia2qnz2 2/8

004. This drug is a Class II antiarrhythmic drug:

a) Flecainide

b) Propranolol

c) Lidocaine

d) Verapamil

005. This drug is a Class III antiarrhythmic drug:

a) Flecainide

b) Sotalol

c) Lidocaine

d) Verapamil006. This drug prolongs repolarization:

a) Flecainide

b) Sotalol

c) Lidocaine

d) Verapamil

Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.

b

b

b

8/7/2019 arrhythmeia2Qnz2

http://slidepdf.com/reader/full/arrhythmeia2qnz2 3/8

007. This drug is a Class IV antiarrhythmic drug:

a) Flecainide

b) Sotalol

c) Lidocaine

d) Verapamil

008. This drug is used in treating supraventricular

tachycardias:a) Digoxin

b) Dobutamine

c) Amrinone

d) Dopamine

009. This drug is associated with Torsades depointes.

a) Flecainide

b) Sotalol

c) Lidocaine

d) Verapamil

Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.

d

a

b

8/7/2019 arrhythmeia2Qnz2

http://slidepdf.com/reader/full/arrhythmeia2qnz2 4/8

010. This drug has beta-adrenergic blockingactivity:

a) Flecainideb) Sotalol

c) Lidocaine

d) Verapamil

011. This drug is useful in terminating atrial but notventricular tachycardias:

a) Flecainide

b) Sotalol

c) Lidocaine

d) Verapamil

012. This is a drug of choice for acute treatmentof ventricular tachycardias:

a) Flecainide

b) Sotalolc) Lidocaine

d) Verapamil

Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.

b

d

c

8/7/2019 arrhythmeia2Qnz2

http://slidepdf.com/reader/full/arrhythmeia2qnz2 5/8

013. The calcium channel blockers have directnegative inotropic effects because they reduce theinward movement of calcium during the actionpotential. Thic consideration is:

a) True

b) False

014. Common unwanted effects of the

dihydropyridines are due to vasodilation. It’s: a) True

b) False

015. Verapamil is a more potent vasodilator thannifedipine. This statement is:

a) True

b) False

016. This drug is contraindicated in patients withmoderate to severe heart failure:

a) Nifedipine

b) Verapamil

c) Both of the above

d) None of the above

Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.

a

b

8/7/2019 arrhythmeia2Qnz2

http://slidepdf.com/reader/full/arrhythmeia2qnz2 6/8

017. This drug is an effective bronchodilator:

a) Nifedipine

b) Verapamil

c) Both of the above.

d) None of the above

018. This drug is used intravenously to terminate

supraventricular tachycardias:a) Nifedipine

b) Verapamil

c) Both of the above

d) None of the above

019. This drug has a little or no direct effect onchronotropy and dromotropy at normal doses

a) Nifedipine

b) Diltiazem

c) Verapamil

d) All of the above

Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.

d

b

8/7/2019 arrhythmeia2Qnz2

http://slidepdf.com/reader/full/arrhythmeia2qnz2 7/8

020. Verapamil has a significant effect onautomaticity in the SA node. It’s:

a) Trueb) False

021. This drug acts by inhibiting slow calciumchannels in the SA and AV nodes:

a) Quinidine

b) Adenosine

c) Flecainide

d) Diltiazem

022. All of the following statements regarding

verapamil are true EXCEPT:

a) It blocks L-type calcium channels

b) It increases heart rate

c) It relaxes coronary artery smooth muscle

d) It depresses cardiac contractility

Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.

a

d

b

8/7/2019 arrhythmeia2Qnz2

http://slidepdf.com/reader/full/arrhythmeia2qnz2 8/8

023. All of the following calcium channel blockersare useful in the treatment of cardiac arrhythmiasEXCEPT:

a) Bepridil

b) Diltiazem

c) Verapamil

d) Nifedipine

024. All of the following are common adverseeffects of calcium channel blockers EXCEPT:

a) Skeletal muscle weakness

b) Dizziness

c) Headache

d) Flushing

025. Tick the adverse reactions characteristic forlidocaine:

a) Agranulocytosis, leucopenia

b) Extrapyramidal disorders

c) Hypotension, paresthesias, convulsions

d) Bronchospasm, dyspepsia

Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.

d

a

c